Trial intelligence / Profile preview

Caffeine/Propranolol for Acute Migraine

NCT01080677Phase 2Completed

Sponsor
Stanford University
Start
Jan 2007
Primary completion
Sep 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of caffeine, propranolol in migraine, sponsored by Stanford University. Started Jan 2007; status: completed.

02

Drugs

caffeinepropranolol
03

Conditions

migraine

Beyond the preview

Go deeper on NCT01080677.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01080677.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call